Exchange Traded Fund Jpm Us Sripa Ucits Etf Usd Acc (JSEU) News

$191?? are you insane??

25,000,000,000 shares x 191 is $4.775 TRILLION market cap

Or they didn’t look at just one trial, nor just one compassionate group, and the trial maturity in the phase iii continues to be monitored.

Are they limited to open a certain number of credit card in a two year period where he lives?

Just asking - because he may not be able to afford it... I know Elite is a penny stock but he would need a lot of pennies....

it's still Bills -1, Jets +1 on mine....o/u 41...

Reminder that Darcy Christopherson now has a 2 year PPO for what he has posted on social media and other communications to innocent parties. He has lost his job over it, for the second time. Let this be a lesson for those who put their mentally ill conspiracy theories before simply being a decent hu

Series C1 Shares means the series C1+ preferred shares of nominal or par value of US$0.0001 each in the capital of the Company carrying the preferred rights and privileges as set out in these Memorandum and Articles.

That can cause a gap that tends to be filled later. I’d rather news hit an hour or two into trading.

LCJR

It was four years ago today that my wife died. I believe that lenz could have saved her, if the medical community was aware of the safety and efficacy of lenz, and of what it is is capable of doing.

Today, we are closer than we have ever been to regulatory Authorization and Approvals.

That doesn’t alter the facts. An investment in AVXL over the past few years has been a disaster.

Buy VNDA @ $4.96

Buy 2000 VNDA @ $4.96 = $9920

all quiet after todays session? I dont understand you people on this board.
After August ended people became nervous because of the readout not being released. Now its been due for so long, its more likely some of the patients have survived for a very long time and they will want to announce

https://amp-oncotarget-com.cdn.ampproject.org/c/s/amp.oncotarget.com/news/pr/mir-b-inhibition-a-strategy-for-treating-metastatic-breast-cancer/

Updated

HALO 2500 shares

VNDA 8000 shares

DAN 10000 shares

Cash neg $53

Could MIKAH buy out elite ?

Not sure about that......... however, I think Ama would be a prime candidate to buy Elite. The King "Not Elvis" Pharmaceuticals.
Projected price........ only Ama knows for sure.

Viva Las Vegas~!

What is this company?

It’s a POS run by an arrogant, incompetent, overcompensated buffoon for a CEO.

How this company conducts its affairs and communicates with its stakeholders is downright deplorable. The fact that this CEO has not been removed long ago speaks volume

Cytovia needs that 116 million in ESHA. I’m thinking they will roll up Naya as well. You will notice that even though merger is done, our shares remain locked up with C1 and C2 shares. That means what folks??? Controlled. All is controlled and ready to be rolled up. Be well. Cuckoo degenerate Kenny.

You are a man of few words and I like that, this is your only post since you were here since 2021. I suppose you are here like me to make a small fortune to add to the cash pile based on what is coming with $PSRU!!! HE HE HE! I like your style. Welcome!

Hey CEO, time to get news out at Tomorrow morning before market open, let today's sellars cry.

CYBL STOCK 10Q FUTURE WAR CONTRACTS + READING SILLY COMMENTS

https://youtu.be/0tXwZh4kdWw

https:// youtu.be/0tXwZh4kdWw

I’m going to take that as a community service bulletin….a positive sign of things to come…?… ;)

So in other words…SOON!
What’s another year among friends. November 2025! WOW! I sure know how to pick my stocks. By the time LBHI pays us the dollar will no longer be the world reserve currency!

$DBGI flying in afterhours (see chart)

https://investorshub.advfn.com/uimage/uploads/2024/10/14/kmtxd0_-_dbgi_chart_afterhours_101424.png

Hey, there’s companies out there that just release news and updates in conjunction with quarterly reports. If I see a company releasing fluff every week I get nervous. I’d rather they stay quiet until they have concrete news.

LCJR

Hey Bobby---love it! They're based in the UK and have a woman CEO that is aggressive.




BUY $BIEL$

Comparing apples to pomegranates. The DJIA doesn’t have the potential for a 10 - 20 bagger over the next couple of years. That is always the trade off with pre-commercial biotechs.